Active ingredient
Docetaxel
70 finished FDA listings contain Docetaxel as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- DOCETAXEL, DOCETAXEL ANHYDROUS
- Dosage forms
- Injection, Injection, Solution, Injection, Solution, Concentrate
- Routes
- Intravenous
- Manufacturers / labelers
- 23
- Strengths listed
- 10 mg/ml · 160 mg/16ml · 160 mg/8ml · 20 mg/2ml · 20 mg/ml · 80 mg/4ml · 80 mg/8ml
- Brand names in FDA listings
- Beizray, Docetaxel, Docivyx
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 72962
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 020449 | SANOFI AVENTIS US | 1996-05-14 | 3 |
| NDA 022234 | HOSPIRA INC | 2011-03-08 | 11 |
| NDA 022534 | SUN PHARM | 2011-05-03 | 3 |
| NDA 201195 | ACCORD HLTHCARE | 2011-06-08 | 1 |
| NDA 201525 | SANDOZ | 2011-06-29 | 4 |
| NDA 203551 | ACTAVIS | 2013-04-12 | 2 |
| ANDA 204193 | DR REDDYS | 2014-11-05 | 5 |
| ANDA 207252 | HENGRUI PHARMA | 2017-08-09 | 4 |
| ANDA 209640 | AMNEAL | 2018-01-19 | 3 |
| ANDA 208859 | MYLAN LABS LTD | 2018-04-30 | 2 |
| ANDA 210072 | MYLAN LABS LTD | 2018-07-02 | 2 |
| ANDA 210848 | MYLAN LABS LTD | 2018-07-06 | 2 |
| ANDA 209634 | MEITHEAL | 2018-08-24 | 1 |
| ANDA 208137 | MYLAN LABS LTD | 2019-04-01 | 1 |
| ANDA 204490 | HIKMA | 2021-01-14 | 2 |
| ANDA 214575 | EUGIA PHARMA | 2021-06-25 | 3 |
| ANDA 213510 | GLAND | 2021-07-01 | 4 |
| NDA 215813 | AVYXA HOLDINGS | 2022-11-22 | 3 |
| ANDA 215744 | ALEMBIC | 2023-02-28 | 5 |
| ANDA 216677 | HERITAGE | 2024-02-28 | 3 |
| NDA 218711 | ZHUHAI | 2024-10-23 | 4 |
| ANDA 213768 | GUANGDONG SUNHO | 2025-05-13 | 2 |
Official labeling on DailyMed
- DOCETAXEL (DOCETAXEL ANHYDROUS) INJECTION, SOLUTION [MYLAN INSTITUTIONAL LLC] · version 4 · 2026-07-23
- DOCETAXEL INJECTION [HERITAGE PHARMACEUTICALS INC. D/B/A AVET PHARMACEUTICALS INC.] · version 2 · 2026-05-13
- BEIZRAY ( DOCETAXEL ) KIT BEIZRAY ( DOCETAXEL ) KIT BEIZRAY (DOCETAXEL) INJECTION, SOLUTION [ZYDUS PHARMACEUTICALS USA INC.] · version 4 · 2025-12-25
- BEIZRAY (DOCETAXEL) INJECTION, SOLUTION [ZHUHAI BEIHAI BIOTECH CO., LTD.] · version 12 · 2025-12-16
- DOCETAXEL INJECTION [BAXTER HEALTHCARE CORPORATION] · version 1 · 2025-12-01
- DOCETAXEL (DOCETAXEL ANHYDROUS) INJECTION, SOLUTION [SAGENT PHARMACEUTICALS] · version 10 · 2025-09-19
- DOCIVYX (DOCETAXEL) INJECTION, SOLUTION [AVYXA PHARMA, LLC] · version 4 · 2025-07-16
- DOCETAXEL INJECTION, SOLUTION, CONCENTRATE [MEITHEAL PHARMACEUTICALS INC.] · version 7 · 2025-05-23
- DOCETAXEL (DOCETAXEL ANHYDROUS) INJECTION, SOLUTION [MYLAN INSTITUTIONAL LLC] · version 8 · 2025-04-29
- DOCETAXEL INJECTION, SOLUTION [HOSPIRA, INC.] · version 7 · 2025-02-03
- DOCETAXEL (DOCETAXEL ANHYDROUS) INJECTION, SOLUTION [HOSPIRA, INC.] · version 4 · 2025-01-24
- DOCETAXEL (DOCETAXEL ANHYDROUS) INJECTION, SOLUTION [HOSPIRA, INC.] · version 7 · 2025-01-23
Showing the 12 most recent of 31 labels.
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.